Zhe Dong

Oct 31, 2024 | mdpi.com | Zhihong Wu |Zhe Dong |Kun Yang |Qingjie Liu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Apr 25, 2024 | bmccancer.biomedcentral.com | Zhe Dong |Gao-Yuan Wang |Dong-Yu Dai |Guan-Jie Qin |Ling-Long Tang |Cheng Xu | +1 more

Correction Open access Published: 25 April 2024 BMC Cancer volume 24, Article number: 528 (2024) Cite this article The Original Article was published on 15 April 2024 Correction to: BMC Cancer 24, 466 (2024)Following publication of the original article [1], the author reported a typesetting error, whereby Tables 1, 2 and 3 were erroneously omitted from the published version. The publishers apologise for this error.

Apr 15, 2024 | bmccancer.biomedcentral.com | Zhe Dong |Gao-Yuan Wang |Guan-Jie Qin |Ling-Long Tang |Cheng Xu |Jun Ma | +1 more

A total of 451 eligible patients diagnosed with recurrent I-IVA nasopharyngeal carcinoma (NPC) between April 2009 and December 2015 were retrospectively identified from the NPC-specific database at the Sun Yat-sen University Cancer Center, which included a total of 10,126 patients.